These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1863 related items for PubMed ID: 7783597

  • 1. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T, Frisk A, Purvèn M, Nilsson LA.
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [Abstract] [Full Text] [Related]

  • 2. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A, Ahmed HJ, Van Dyck E, Lagergård T.
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [Abstract] [Full Text] [Related]

  • 3. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers.
    Alou L, Aguilar L, Sevillano D, Giménez MJ, Laguna B, Echeverría O, Carcas A, Lubomirov R, Casal J, Prieto J.
    J Antimicrob Chemother; 2005 May; 55(5):742-7. PubMed ID: 15761068
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.
    Leijh PC, van den Barselaar MT, van Zwet TL, Daha MR, van Furth R.
    J Clin Invest; 1979 Apr; 63(4):772-84. PubMed ID: 374424
    [Abstract] [Full Text] [Related]

  • 10. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L, Hällgren R, Venge P.
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum opsonic capacity against Yersinia enterocolitica O:3 in yersiniosis patients with or without reactive arthritis.
    Tertti R, Granfors K, Lahesmaa-Rantala R, Toivanen A.
    Clin Exp Immunol; 1989 May; 76(2):227-32. PubMed ID: 2758695
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3.
    Fine DP, Kirk JL, Schiffman G, Schweinle JE, Guckian JC.
    J Lab Clin Med; 1988 Oct; 112(4):487-97. PubMed ID: 3171357
    [Abstract] [Full Text] [Related]

  • 19. Kinetics of phagocytosis and killing of E. coli by murine macrophages in presence of different serum preparations.
    Adinolfi LE, Dilillo M, Tripodi MF, Utili R, Bonventre PF, Ruggiero G.
    Microbiologica; 1988 Jan; 11(1):13-20. PubMed ID: 3280948
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 94.